Brief: Sol-Gel And Mayne Pharma Announce The Purchase Of Epsolay And Twyneo In The U.S.

SOL-GEL TECHNOLOGIES

17/04/2025 13:49

April 17 (Reuters) - Mayne Pharma Group Ltd MYX.AX:

SOL-GEL AND MAYNE PHARMA ANNOUNCE THE PURCHASE OF EPSOLAY® AND TWYNEO® IN THE U.S.

SOL-GEL- TO RECEIVE $16 MILLION DURING 2025

SOL-GEL- SGT-610 PHASE III TRIAL TOP-LINE RESULTS EXPECTED Q4 2026

Source text: ID:nGNX9BXqdP

Further company coverage: MYX.AX

 ((Reuters.Briefs@thomsonreuters.com;))